|
Peter Boyle, FRSE FFPH FRCPS(Glas) FRCP(Edin) FMedSci, (born 8, June 1951) is a British epidemiologist. He has done research on globalisation of cancer, where he has shown the dramatic increase of cancer in low- and medium income countries. ==Biography== Boyle was born in Glasgow, Scotland and studied statistics at the University of Glasgow (BSC in 1974) and received a Doctor of Philosophy degree in Epidemiology in 1985 from the University of Glasgow, Faculty of Medicine).〔(University of Glasgow )〕 He initially wanted to become a teacher but became fascinated in Science and worked from 1974–77 as a statistician at the University Department of Medicine, Glasgow and the following 7 years at the West of Scotland Cancer Surveillance Unit in Glasgow. In 1984 he moved to Boston and worked at the Departments of Biostatistics and Epidemiology, Harvard School of Public Health and the Division of Biostatistics and Epidemiology, Dana-Farber Cancer Institute as Instructor and Assistant Professor. During this time Boyle has coauthored his first two Lancet publications on cancer mortality in Scotland. In 1986, he returned to Europe and became Scientist and Group Head at the International Agency for Research on Cancer, IARC, in Lyon, France. In 1991 he again moved, this time to Milan, Italy to become the first chairperson of the Department of Epidemiology and Biostatistics and Director of the Division of Cancer Control of the European Institute of Oncology, EIO.〔(EIO homepage, history of the Institute )〕 During this time the European Code against Cancer was developed〔(''European Code against Cancer'' )〕 and updated to its current 3rd edition under the leadership of Peter Boyle (2003). In 2003 he was elected the 4th Director of IARC and moved back to Lyon, a position he held from 2004–2008.〔(IARC press release N°148, May 2003 )〕 He stood as a candidate for a second term as Director but was not successful. In 2009 Peter Boyle was the founding President of a new private funded research and consulting company, named International Prevention Research Institute, based in Lyon, France.〔(company directory of the chambre de commerce de Lyon )〕 Beside his main appointments he holds several (visiting and/or honorary) professorships from different Universities, incl. University of Birmingham (1996–), University of Milan (1996–2004), University of Pittsburgh (1996–2002), University of Glasgow (1998–), University of Innsbruck (1998), University of Oxford (2003–). He was editor-in-chief (together with Carlo La Vecchia and Alec Walker) of the Journal of Epidemiology and Biostatistics from 1995–2003 and of the European Journal of Cancer from 1990–1994. Peter Boyle was associate editor of ''Oncology and Haematology Literature Service'' from 1993–1998 and still is it for the journals Annals of Oncology (since 1999) and the British Journal of Urology International (since 2002). Furthermore he was or is a member of the editorial boards of the following Journals, ''Cancer Causes and Control'' (1990–1994), ''Swiss Journal of Social and Preventive Medicine'' (1990–present), British Journal of Cancer (1990–1997), ''Prospectives'' (1990–99), ''BPH Observer'' (1990–99), The Breast (journal) (1991–97), Oral Oncology (1991–present), ''European R and D Database'' (1993–98), Lung Cancer (1995–present), ''Journal of Radiation Therapy'' (1996–present), ''European Cancer News'' (1996–98), Journal of Gynecologic Oncology (1996–present), Annals of Oncology (1996–present), ''URO'' (Portuguese Journal of Urology) (1996–present), Breast Cancer Online (1999–present), Lancet (2003–present), Nature Reviews Urology (2004–present), Molecular Oncology (2006–present). Peter Boyle has published more than 500 articles in scientific journals and is co-/author of some 23 books, including textbooks and cancer atlases.〔(Articles written/co-written by Peter Boyle – Pubmed )〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Peter Boyle (epidemiologist)」の詳細全文を読む スポンサード リンク
|